Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

The purpose of this study is to evaluate the immunogenicity and immune protection of COVID-19, especially the recently prevalent strains, against the background of current immunization in Chinese population

Inclusion Criteria:

1. He was infected with COVID-19 from November to December 2022;
2. Have not been infected with COVID-19 (the subject said that he was not infected and signed the informed consent form);
3. Those who agree and sign the informed consent form.

Exclusion Criteria:

1. Missing or incomplete questionnaires that affect research results;
2. Individuals with combined dysfunction of important organs such as the heart, liver, and lungs;
3. Mental and behavioral abnormalities;
4. Intellectual disability;
5. Under 18 years old or over 75 years old;
6. Low understanding and communication skills.